Arcturus Therapeutics to Attend the Following Investor Conferences
Yahoo! Finance
SAN DIEGO, September 27, 2022--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences.
Continue Reading